|
Mar 28
|
Entera Bio Announces Full Year 2024 Financial Results and Provides Business Updates
|
|
Mar 18
|
Opko and Entera focus on oral care for obesity and metabolic disorders
|
|
Mar 17
|
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
|